{
  "text": "Lymphoscintigraphy with 123I-labelled epidermal growth factor \n We have used 123I-labelled epidermal growth factor (EGF) scans to study 14 patients with advanced cervical cancer.\n Abnormal lymph node imaging was seen most clearly 6-8 h after the injection and revealed abnormal uptake by pelvic lymph nodes in 11 patients.\n 4 of these 11 had abnormal computerised tomographic and ultrasound scans; in the other 7 conventional radiology did not confirm the presence of disease.",
  "category": "C04"
}